These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 3781709)
1. Muramyl dipeptide protects decomplemented mice from surgically-induced infection. Cobb JP; Brown CM; Brown GL; Polk HC Int J Immunopharmacol; 1986; 8(7):799-803. PubMed ID: 3781709 [TBL] [Abstract][Full Text] [Related]
2. Pretreatment with antigen or adjuvant, and the preventability of allergic encephalomyelitis induced by basic protein with synthetic muramyl dipeptide in comparison with Freund's complete adjuvant. Mitsuzawa E; Yasuda T; Tamura N; Ohtani S Jpn J Exp Med; 1984 Jun; 54(3):97-107. PubMed ID: 6084088 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of copovithane as a nonspecific immunomodulator in surgically simulated sepsis. Hershman MJ; Trachtenberg LS; Pietsch JD; Mooney TH; DeWeese RC; Cheadle WG J Invest Surg; 1989; 2(4):423-9. PubMed ID: 2488006 [TBL] [Abstract][Full Text] [Related]
4. The role of muramyl dipeptide in the therapy of established experimental bacterial infection. Ausobsky JR; Scuitto M; Trachtenberg LS; Polk HC Br J Exp Pathol; 1984 Feb; 65(1):1-9. PubMed ID: 6365142 [TBL] [Abstract][Full Text] [Related]
5. Muramyl dipeptide increases tolerance to shock and bacterial challenge in mice. Ausobsky JR; Cheadle WG; Brosky BG; Polk HC Br J Surg; 1984 Feb; 71(2):151-3. PubMed ID: 6362769 [TBL] [Abstract][Full Text] [Related]
6. Fate of the synthetic immunoadjuvant, muramyl dipeptide (14C-labelled) in the mouse. Parant M; Parant F; Chedid L; Yapo A; Petit JF; Lederer E Int J Immunopharmacol; 1979; 1(1):35-41. PubMed ID: 551094 [TBL] [Abstract][Full Text] [Related]
7. Muramyl dipeptide enhances survival from experimental peritonitis. Brown GL; Foshee H; Pietsch J; Polk HC Arch Surg; 1986 Jan; 121(1):47-9. PubMed ID: 3942499 [TBL] [Abstract][Full Text] [Related]
8. Muramyl dipeptide analogues as potentiators of the antitumor action of endotoxin. Bloksma N; Hofhuis FM; Willers JM Cancer Immunol Immunother; 1985; 19(3):205-10. PubMed ID: 3847290 [TBL] [Abstract][Full Text] [Related]
9. Nonspecific enhancement of resistance to bacterial infection: evidence of an effect supplemental to antibiotics. Polk HC; Galland RB; Ausobsky JR Ann Surg; 1982 Oct; 196(4):436-41. PubMed ID: 7125729 [TBL] [Abstract][Full Text] [Related]
10. Stimulatory effects of muramyl dipeptide upon neutrophils isolated from a local bacterial infection. Lamont PM; Maier KG; Melton L; Polk HC Br J Exp Pathol; 1987 Oct; 68(5):655-61. PubMed ID: 3318904 [TBL] [Abstract][Full Text] [Related]
11. Effects of muramyl dipeptide and lead acetate on carbon clearance and endotoxin-induced mortality in mice. Cheadle WG; Ausobsky JR; Trachtenberg LS; Lamont P; Polk HC Am Surg; 1986 Nov; 52(11):613-7. PubMed ID: 3535600 [TBL] [Abstract][Full Text] [Related]
19. Non-specific stimulation of host defenses against a bacterial challenge in malnourished hosts. Galland RB; Polk HC Br J Surg; 1982 Nov; 69(11):665-8. PubMed ID: 6751460 [TBL] [Abstract][Full Text] [Related]
20. The fate of nor-muramyl dipeptide (3H-labelled) after local administration in incomplete Freund's adjuvant in the guinea pig. Hudson AM Int J Immunopharmacol; 1984; 6(2):119-24. PubMed ID: 6735534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]